The CanTx Science
This exciting new joint venture unites cutting-edge technology from industry with that from world-class academia.
NOVOGEN has developed super-benzopyran (SBP) drugs designed to kill chemo-resistant cancer stem cells.
YALE has uniquely identified and isolated the ovarian cancer stem cells that are responsible for tumor formation, heterogeneity, chemo-resistance and recurrence.
This union has produced Cantrixil®, a product designed to be administered intra-peritoneally to patients with cancers confined to the abdominal cavity, starting with patients with ovarian cancer.